David A. Siegel Fusion Pharmaceuticals Inc. Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$7.9 - $21.32 $1,580 - $4,264
200 Added 1.74%
11,700 $249,000
Q4 2023

Feb 14, 2024
SELL
$2.48 - $9.65 $51,088 - $198,790
-20,600 Reduced 64.17%
11,500 $110,000
Q3 2023

Nov 14, 2023
SELL
$2.37 - $4.63 $78,921 - $154,179
-33,300 Reduced 50.92%
32,100 $83,000
Q2 2023

Aug 14, 2023
BUY
$3.47 - $5.33 $102,365 - $157,235
29,500 Added 82.17%
65,400 $305,000
Q1 2023

May 15, 2023
BUY
$3.03 - $5.13 $108,777 - $184,167
35,900 New
35,900 $135,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email